by Sue Robbins | Sep 17, 2019 | Migraine
Denmark’s Lundbeck has agreed to buy Alder BioPharmaceuticals in a deal valued at almost $2 billion, hoping to reap profits from a potential blockbuster migraine drug. Read more here.
by Sue Robbins | Sep 16, 2019 | Migraine
Emgality is a brand-name prescription medication that’s used in adults to prevent chronic and episodic migraines, and treat episodic cluster headaches. Emgality comes as a pre-filled pen or syringe that you’ll use to give yourself a monthly injection. Read...
by Sue Robbins | Sep 14, 2019 | Migraine
Migraine patterns in women are closely linked to various reproductive stages. During puberty, migraine prevalence becomes more pronounced in females compared with males, and remains so throughout the remaining life span. Read more here.
by Sue Robbins | Sep 12, 2019 | Migraine
A study investigating the effects of weather and air pollution on migraine found that higher relative humidity was associated with higher odds of migraines during warmer seasons. Traffic-related pollutants was linked with migraines in colder weather. Read more...
by Sue Robbins | Sep 11, 2019 | Migraine
It is imperative for healthcare providers to speak honestly with their patients about diet and food triggers, which can be difficult to address in migraine treatment. Read more here.
